日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Population Pharmacokinetic Analysis of MIT-001, a Novel Ferroptosis Inhibitor, for Dose Optimization

MIT-001（一种新型铁死亡抑制剂）的群体药代动力学分析及其剂量优化

期刊:Journal of Clinical Pharmacology
影响因子:2.3
doi:10.1002/jcph.70189
Bae, Sungyeun; Kim, Eunwoo; Rhee, Su-Jin; Kim, Soonha; Yu, Kyung-Sang; Lee, SeungHwan
铁死亡
发表日期：2026
文献求助 收藏

Toward Genotype-Informed Dosing of Voriconazole: Head-to-Head Simulations Across CYP2C19 Phenotypes Using Population Pharmacokinetic Models

基于基因型指导的伏立康唑给药：利用群体药代动力学模型对CYP2C19表型进行头对头模拟

期刊:Pharmaceutics
影响因子:5.5
doi:10.3390/pharmaceutics17111398
Lee, Yeobin; Lee, Nai; Rhee, Su-Jin; Kim, Yun
发表日期：2025
文献求助 收藏

Disproportionality analysis of Raynaud's phenomenon associated with calcitonin gene-related peptide inhibitors using the Food and Drug Administration adverse event reporting system

利用美国食品药品监督管理局不良事件报告系统对与降钙素基因相关肽抑制剂相关的雷诺现象进行比例失调分析

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-87421-w
Lee, Nai; Ok, Ji Hoon; Rhee, Su-Jin; Kim, Yun
发表日期：2025
文献求助 收藏

Navigating Recent Changes in Dosing Information: Dynamics of FDA-Approved Monoclonal Antibodies in Post-Marketing Realities

应对近期剂量信息的变化：FDA批准的单克隆抗体在上市后实际情况中的动态变化

期刊:Cts-Clinical and Translational Science
影响因子:2.8
doi:10.1111/cts.70125
Lee, Nai; Rhee, Su-Jin; Koo, Seong Min; Kim, So Won; Lee, Gyo Eun; Yie, Yoon A; Kim, Yun
单克隆抗体
发表日期：2025
文献求助 收藏

Evaluating the association between migraine treatments and tinnitus: Insights from the US Food and Drug Administration adverse event reporting system

评估偏头痛治疗与耳鸣之间的关联：来自美国食品药品监督管理局不良事件报告系统的启示

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0330493
Kim, Yun; Yook, Yeabin; Rhee, Su-Jin
偏头痛
神经科学
发表日期：2025
文献求助 收藏

Optimal Once-Daily Busulfan Administration in Pediatric Patients: A Simulation-Based Investigation of Intravenous Infusion Times

儿童患者每日一次布苏凡最佳给药方案：基于模拟的静脉输注时间研究

期刊:Drug Design Development and Therapy
影响因子:5.1
doi:10.2147/DDDT.S451970
Kim, Yun; Moon, Sungha; Rhee, Su-Jin
发表日期：2024
文献求助 收藏

Key Considerations for Phase 2 or 3 Clinical Study Design of Anti-Inflammatory Agent for COVID-19 Treatment

抗炎药物治疗 COVID-19 的 II 期或 III 期临床研究设计的关键考虑因素

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2022.842836
Park, Yewon; Na, Joo Young; Cho, Joo-Youn; Oh, Jaeseong; Rhee, Su-Jin
发表日期：2022
文献求助 收藏

Anti-Obesity Potential of Ponciri Fructus: Effects of Extracts, Fractions and Compounds on Adipogenesis in 3T3-L1 Preadipocytes

枳实的抗肥胖潜力：提取物、组分和化合物对3T3-L1前脂肪细胞脂肪生成的影响

期刊:Molecules
影响因子:4.6
doi:10.3390/molecules27030676
Lamichhane, Gopal; Pandeya, Prakash Raj; Lamichhane, Ramakanta; Rhee, Su-Jin; Devkota, Hari Prasad; Jung, Hyun-Ju
细胞生物学
肥胖
代谢
发表日期：2022
文献求助 收藏

Population pharmacokinetic analysis of sildenafil in term and preterm infants with pulmonary arterial hypertension

对足月和早产肺动脉高压患儿进行西地那非群体药代动力学分析

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-022-11038-6
Rhee, Su-Jin; Shin, Seung Han; Oh, Jaeseong; Jung, Young Hwa; Choi, Chang Won; Kim, Han-Suk; Yu, Kyung-Sang
肺动脉高压
心血管
发表日期：2022
文献求助 收藏

Antiobesity Activity of Two Polyherbal Formulations in High-Fat Diet-Induced Obese C57BL/6J Mice

两种复方草药制剂对高脂饮食诱导肥胖的C57BL/6J小鼠的抗肥胖活性

期刊:Biomed Research International
影响因子:2.3
doi:10.1155/2022/9120259
Pandeya, Prakash Raj; Lamichhane, Gopal; Lamichhane, Ramakanta; Luo, Jiao; Li, Xiao-Jun; Rhee, Su-Jin; Xiangqian, Liu; Jung, Hyun-Ju
肥胖
代谢
发表日期：2022
文献求助 收藏